An update on the treatment of type 1 and type 2 diabetes mellitus: focus on insulin detemir, a long-acting human insulin analog.
about
Cardiomyocytes mediate anti-angiogenesis in type 2 diabetic rats through the exosomal transfer of miR-320 into endothelial cellsDevelopment of the endocrine pancreas and novel strategies for β-cell mass restoration and diabetes therapy.Pathologic function and therapeutic potential of exosomes in cardiovascular disease.Detemir as a once-daily basal insulin in type 2 diabetesTreatment of type 1 and type 2 diabetes mellitus with insulin detemir, a long-acting insulin analog.Genetic modifications of pigs for medicine and agriculture.Comparison of a multiple daily insulin injection regimen (glargine or detemir once daily plus prandial insulin aspart) and continuous subcutaneous insulin infusion (aspart) in short-term intensive insulin therapy for poorly controlled type 2 diabeteCost-effectiveness of insulin detemir: a systematic review.Insulin detemir: a review of its use in the management of diabetes mellitus.Differentiation of stem cells into insulin-producing cells: current status and challenges.Bioavailability of insulin detemir and human insulin at the level of peripheral interstitial fluid in humans, assessed by open-flow microperfusion.Efficacy and Safety of Insulin Glargine 300 U/mL versus 100 U/mL in Diabetes Mellitus: A Comprehensive Review of the Literature.
P2860
Q33995548-4C7287EB-8317-45C5-AFD4-5D47A324DA1BQ34485165-62A0E4F7-3BE6-44F5-B723-1FE55221CFFFQ34717025-51A498E4-C178-442E-B0F0-A6C071431CF8Q35683978-1A35E450-6DD5-45D8-8CC9-A4DF63CEC1E8Q36139042-826D3DC9-CE39-4E21-9A6F-01488BE6A1CDQ36466394-DD65A7EF-A547-4C7D-8F1A-940905BF70A6Q36869489-5C7D6A20-AA2B-44DD-8E60-EBE708BF0780Q37941075-C17DEA1B-A3C2-4E87-842B-E9E0205F1C05Q38056540-641D6189-A9FB-415E-856B-AC2009A03E51Q38071243-E57F2FAA-E74B-4A49-83E9-155FFAA53D22Q40639994-34A6A43F-8531-4BC3-87E1-18549510C32FQ52605864-0A064084-4F2F-42C2-8FEB-780F8CC190F8
P2860
An update on the treatment of type 1 and type 2 diabetes mellitus: focus on insulin detemir, a long-acting human insulin analog.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
An update on the treatment of ...... g-acting human insulin analog.
@ast
An update on the treatment of ...... g-acting human insulin analog.
@en
type
label
An update on the treatment of ...... g-acting human insulin analog.
@ast
An update on the treatment of ...... g-acting human insulin analog.
@en
prefLabel
An update on the treatment of ...... g-acting human insulin analog.
@ast
An update on the treatment of ...... g-acting human insulin analog.
@en
P2860
P921
P356
P1476
An update on the treatment of ...... g-acting human insulin analog.
@en
P2093
Katarina Raslova
P2860
P304
P356
10.2147/VHRM.S10397
P407
P577
2010-06-01T00:00:00Z